Shao Wei-Li's Form 4/A amendment
AmendedOmada Health, Inc. (OMDA) · filed Sep 4, 2026
- Accession no.
- 0001610717-26-000404
- Filed
- Sep 4, 2026, 4:14 PM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Aug 12, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $235.6K. It was filed 23 days after the trade.
This amendment replaces 0001610717-26-000357 (filed Aug 12, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shao Wei-LiCIK 0002069137 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | SSaleDisposed | −9,418 | $25.02 | −$235,607.28 | 307,372 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2
This Form 4/A is being filed solely to correct the number of shares reported as sold pursuant to the Reporting Person's 10b5-1 plan on August 12, 2026. The amount of shares sold has been adjusted to reflect the addition of 552 shares that were inadvertently omitted from the original Form 4 filed with the U.S. Securities and Exchange Commission on August 12, 2026. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 remains accurate.